Asia Pacific Respiratory Care Device Market

The report "Asia Pacific Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), & End User (Hospitals, ASCs) - Forecast to 2031" is projected to reach USD 8.76 billion by 2031 from USD 5.85 billion in 2026, at a CAGR of 8.4% during the forecast period.

Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Asia Pacific Respiratory Care Device Market, by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), & End User (Hospitals, ASCs) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-respiratory-care-devices-market-27091582.html

The Asia Pacific respiratory care devices market is primarily driven by the rising incidence of respiratory disorders, including COPD, asthma, and sleep apnea. These conditions are largely attributed to rising air pollution levels, higher smoking rates, and a rapidly aging population, particularly in countries like China, India, and Japan. Additionally, the ongoing development of healthcare facilities and increased healthcare spending across the region are improving access to advanced diagnostic, monitoring, and therapeutic respiratory devices. There is also a growing awareness of the importance of early diagnosis and effective disease management, supported by government health programs, which has contributed to greater use of these devices. Furthermore, the trend toward home-based respiratory care and the demand for portable, user-friendly devices, along with technological innovations like IoT-enabled monitoring systems and intelligent therapy solutions, are further propelling market growth in the Asia Pacific region.

Therapeutic respiratory care devices accounted for the largest share of the Asia Pacific respiratory care devices market, by product, in 2025.

Therapeutic respiratory care devices accounted for the largest share of the Asia Pacific respiratory care devices market. These devices play a crucial role in treating and providing follow-up care for patients with respiratory conditions such as COPD, asthma, pneumonia, and sleep apnea. Equipment like ventilators, oxygen therapy kits, nebulizers, and CPAP/BiPAP machines is extensively used in both home and hospital settings. In countries like China and India, which have large populations and a high prevalence of respiratory diseases, the usage of these therapeutic products has been further driven by increased ICU admissions and a rise in post-COVID respiratory issues. Additionally, the ongoing shift toward home care and the demand for ultra-light, portable devices continue to enhance the prominence of this product category in the Asia Pacific market, supported by technological advancements and increased affordability.

Hospitals segment accounted for the largest share of the Asia Pacific respiratory care devices market, by end user, in 2025.

Hospitals are the largest end users in the Asia Pacific respiratory care devices market, serving as primary centers for the treatment of both acute and chronic respiratory diseases that require specialized medical care. They primarily utilize high-end, expensive equipment, such as ventilators, oxygen delivery systems, and patient monitoring devices, particularly in intensive care units, emergency departments, and surgical suites. The increasing prevalence of respiratory diseases, along with a rise in the number of surgeries and ICU admissions in major countries like China, India, and Japan, has led to more device installations within hospitals. Additionally, ongoing investments in healthcare infrastructure, the development of critical care facilities, and the modernization of medical technology by both public and private healthcare providers have further strengthened the vital role of hospitals in the Asia Pacific respiratory care devices market.

In 2025, India accounted for the largest share of the Asia Pacific respiratory care devices market.

India accounts for the largest share of the Asia Pacific respiratory care devices market, primarily due to its massive population and the high prevalence of respiratory diseases, including asthma, COPD, and sleep apnea. The incidence of chronic respiratory diseases has surged due to factors such as air pollution, increased tobacco consumption, and occupational hazards. As a result, the demand for therapeutic and monitoring devices remains strong. Additionally, the rapid development of healthcare infrastructure, the rise of private hospitals, and increased government healthcare budgets have contributed to greater availability of advanced respiratory care solutions, not only in metropolitan areas but also in semi-urban areas. Furthermore, market growth in India is significantly driven by increasing public awareness of the benefits of early diagnosis and effective long-term disease management, as well as the growing trend of home-based respiratory therapy and portable devices. Consequently, India leads the Asia Pacific respiratory care devices market.

Key Market Players

The key players in the Asia Pacific respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), and Masimo (US), among others.

Don’t miss out on business opportunities in Asia Pacific respiratory care devices market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com